Attys Want J&J CEO To Testify In Risperdal Breast-Growth Case

Law360, New York (September 18, 2012, 7:01 PM EDT) -- The CEO of Johnson & Johnson should be forced to testify in a trial alleging a boy developed breasts because of treatment with antipsychotic Risperdal, attorneys for the teen told a Philadelphia court Monday, saying the executive was intimately involved with off-label marketing to children.

The teenager’s case, one of more than 80 in Philadelphia against J&J unit Ortho-McNeil-Janssen Pharmaceuticals Inc., will be severely undermined if a jury can’t hear firsthand from CEO Alex Gorsky about his role in effort to boost sales of the controversial...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.